Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Creative Medical Technology Holdings, Inc. (CELZ)

NASDAQ

$2,21

$--

(0,00%)

Creative Medical Technology Holdings, Inc. (CELZ) Live Price Chart

Page last updated: 2026-05-04 18:14:00

Key Market Data

Market Cap	$8,15M
Open	$2,20
High	$51,45
Low	$1,50
Previous Close	$2,24
Price Change	--
Percentage Change	0,00%
Volume	29K

Creative Medical Technology Holdings, Inc. (CELZ) Stock Price Today

Creative Medical Technology Holdings, Inc. (CELZ) is currently trading at $2,21 as of 2026-05-04 18:14:00, reflecting a 0,00% move ($-0,00) from the previous close.

In the short term, the stock has returned +3,04% over the past four weeks. Over the last 12 months, Creative Medical Technology Holdings, Inc. has recorded a +8,09% price change, indicating a Stable performance relative to the broader market.

Creative Medical Technology Holdings, Inc. (CELZ) 7-Day Stock Price Changes

Over the past seven days, Creative Medical Technology Holdings, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $2,25 to the latest recorded price of $2,21, reflecting an intraday change of 0,00%. Daily movements highlight shifts in trading volume (29 113), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CELZ has delivered a +3,04% return over the past month and a +8,09% change in the last 12 months, indicating a Stable trend relative to its broader sector peers.

How to Buy Creative Medical Technology Holdings, Inc. (CELZ)

You can buy and trade CELZ on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CELZ and Execute Your Trade

Open the trading page, enter CELZ in the search bar, select the amount of CELZ you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Creative Medical Technology Holdings, Inc. (CELZ)?

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Creative Medical Technology Holdings, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	4
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.creativemedicaltechnology.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Creative Medical Technology Holdings, Inc.?

The latest trading price for Creative Medical Technology Holdings, Inc. (Common Stock) is $ 2,21, compared with a previous closing price of $ 2,24. That means the stock has moved 0,00% so far today. Intraday price updates and recent trading activity for CELZ can be tracked on the live chart and quote section on this page.

2.Is Creative Medical Technology Holdings, Inc. stock going up or down?

Looking at recent performances, CELZ has returned +3,04% over the past month, -25,76% over the last six months and +8,09% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Stable price momentum for Creative Medical Technology Holdings, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does CELZ currently sit relative to its 52-week high and low?

In the most recent 52-week period, Creative Medical Technology Holdings, Inc. has traded between a low of $ 1,50 and a high of $ 6,25. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CELZ is currently nearer the top or the bottom of its one-year trading band.

4.How is Creative Medical Technology Holdings, Inc. classified by sector and industry?

Creative Medical Technology Holdings, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Creative Medical Technology Holdings, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CELZ’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Creative Medical Technology Holdings, Inc.’s performance.

5.Where is Creative Medical Technology Holdings, Inc. listed and how large is it by market value?

Creative Medical Technology Holdings, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 8,15M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Creative Medical Technology Holdings, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CELZ's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1,62 summarises how much profit Creative Medical Technology Holdings, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Creative Medical Technology Holdings, Inc.'s financial performance over time?

To follow Creative Medical Technology Holdings, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CELZ is performing and how the market is responding.

8.When is Creative Medical Technology Holdings, Inc. expected to report earnings?

Creative Medical Technology Holdings, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CELZ, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Creative Medical Technology Holdings, Inc.'s earnings reports?

Creative Medical Technology Holdings, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CELZ is meeting, beating or missing expectations.

10.How can I stay informed about Creative Medical Technology Holdings, Inc.'s results and guidance?

You can stay up to date on Creative Medical Technology Holdings, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CELZ on this page helps you see how new information is being reflected in the stock.

11.Does Creative Medical Technology Holdings, Inc. pay a regular cash dividend to its shareholders?

Creative Medical Technology Holdings, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CELZ's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CELZ?

Based on the latest earnings data, CELZ has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Creative Medical Technology Holdings, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Creative Medical Technology Holdings, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Creative Medical Technology Holdings, Inc.?

Creative Medical Technology Holdings, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CELZ valued in terms of P/E ratio and EPS?

Creative Medical Technology Holdings, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1,62. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Creative Medical Technology Holdings, Inc.'s earnings. Comparing CELZ's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CELZ-to-USD Calculator

Amount

CELZ

USD

1 CELZ = 2,205 USD